ALNY icon

Alnylam Pharmaceuticals
ALNY

Overview Fund Activity

472 hedge funds and large institutions have $22.5B invested in Alnylam Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 163 increasing their positions, 152 reducing their positions, and 54 closing their positions.

Holders
472
Holders Change
–
Holders Change %
0%
% of All Funds
7.44%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.09%
New
55
Increased
163
Reduced
152
Closed
54
Calls
$119M
Puts
$162M
Net Calls
-$42.2M
Net Calls Change
-$77M

Top Buyers

1
Capital International Investors
1
Capital International Investors
California
$547M
2
Morgan Stanley
2
Morgan Stanley
New York
$357M
3
Ameriprise
3
Ameriprise
Minnesota
$119M
4
Bank of New York Mellon
4
Bank of New York Mellon
New York
$147M
5
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$615M

Top Sellers

1
Norges Bank
1
Norges Bank
Norway
$134M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$2.37B
3
Bank of America
3
Bank of America
North Carolina
$66.9M
4
Balyasny Asset Management
4
Balyasny Asset Management
Illinois
$0
5
Baillie Gifford & Co
5
Baillie Gifford & Co
United Kingdom
$1.59B
Name Market Value Shares Shares
Change 		Shares
Change %
Wolverine Trading
526
Wolverine Trading
Illinois
– – – –
CA
527
Centerpoint Advisors
Massachusetts
$0 2 – –
Group One Trading
528
Group One Trading
Illinois
– – – –
AW
529
Avion Wealth
Texas
$0 3 +3 New
18 19 20 21
22